| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
TSC1 |
TSC1, KIAA0243, TSC: Hamartin |
3.202 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
GIT1 |
GIT1: ARF GTPase-activating protein GIT1 |
3.202 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.202 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
HDLBP |
HDLBP, HBP, VGL: Vigilin |
3.202 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
3.202 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
3.202 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
EP300 |
IPI00478752 |
3.202 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
USP47 |
USP47: Ubiquitin carboxyl-terminal hydrolase 47 |
3.202 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
3.202 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
TXNRD1 |
TXNRD1: Thioredoxin reductase 1, cytoplasmic precursor |
3.202 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CHAF1B |
CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B |
3.202 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
3.202 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
MAP2K4 |
MAP2K4, JNKK1, MKK4, PRKMK4, SERK1: Dual specificity mitogen-activated protein k |
3.202 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
3.202 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
3.202 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
TTN |
IPI00179357 |
3.202 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
3.202 |
Evidence |
|
| UNG |
IPI00011069 |
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
3.202 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
3.202 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
THOP1 |
THOP1: Thimet oligopeptidase |
3.202 |
Evidence |
|
| ENO2 |
ENO2: Gamma-enolase |
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
3.202 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
3.202 |
Evidence |
|
| POLB |
POLB: DNA polymerase beta |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
3.202 |
Evidence |
|
| GPI |
GPI: Glucose-6-phosphate isomerase |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
3.202 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
3.202 |
Evidence |
|